This week we do have a few products that were approved with new indications. We have updates for you from the FDA on a new indication for Pomalyst for Kaposi sarcoma and approval of Kynmobi to treat off-episodes in Parkinsons disease. And also this week, approval of the combination Opdivo and Yervoy for mNSCLC with PD-L1 expression. Don't forget to like, share, and subscribe! Enjoy!